Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanoparticles | 6 | 2024 | 273 | 1.790 |
Why?
|
| Photosensitizing Agents | 3 | 2021 | 33 | 1.540 |
Why?
|
| Quercetin | 2 | 2021 | 14 | 0.910 |
Why?
|
| Isoindoles | 2 | 2021 | 5 | 0.910 |
Why?
|
| Zinc Compounds | 2 | 2021 | 4 | 0.910 |
Why?
|
| Organometallic Compounds | 2 | 2021 | 40 | 0.870 |
Why?
|
| Zebrafish | 1 | 2024 | 93 | 0.870 |
Why?
|
| Polymers | 2 | 2019 | 114 | 0.750 |
Why?
|
| Biocompatible Materials | 2 | 2021 | 90 | 0.740 |
Why?
|
| Photochemotherapy | 5 | 2021 | 39 | 0.730 |
Why?
|
| Liposomes | 1 | 2021 | 142 | 0.680 |
Why?
|
| Theranostic Nanomedicine | 1 | 2019 | 22 | 0.630 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 657 | 0.490 |
Why?
|
| Lignin | 3 | 2021 | 15 | 0.400 |
Why?
|
| Cell Survival | 3 | 2024 | 394 | 0.390 |
Why?
|
| MCF-7 Cells | 3 | 2021 | 33 | 0.390 |
Why?
|
| Light | 2 | 2021 | 117 | 0.350 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2021 | 545 | 0.350 |
Why?
|
| Antioxidants | 3 | 2021 | 220 | 0.340 |
Why?
|
| Anti-Infective Agents | 2 | 2020 | 77 | 0.320 |
Why?
|
| Hydrogels | 2 | 2024 | 51 | 0.270 |
Why?
|
| Animals | 5 | 2024 | 9960 | 0.250 |
Why?
|
| Lignans | 1 | 2024 | 10 | 0.240 |
Why?
|
| Ear, Inner | 1 | 2024 | 9 | 0.240 |
Why?
|
| Biphenyl Compounds | 1 | 2024 | 22 | 0.240 |
Why?
|
| Drug Delivery Systems | 2 | 2024 | 216 | 0.240 |
Why?
|
| Cisplatin | 1 | 2024 | 172 | 0.220 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2021 | 43 | 0.210 |
Why?
|
| Reactive Oxygen Species | 2 | 2021 | 278 | 0.200 |
Why?
|
| Cell Line | 1 | 2024 | 672 | 0.200 |
Why?
|
| Nanocapsules | 1 | 2021 | 4 | 0.190 |
Why?
|
| Neoplasms | 2 | 2021 | 755 | 0.190 |
Why?
|
| Drug Liberation | 1 | 2021 | 23 | 0.190 |
Why?
|
| Delayed-Action Preparations | 1 | 2021 | 38 | 0.180 |
Why?
|
| Porphyrins | 1 | 2021 | 19 | 0.180 |
Why?
|
| Cell Membrane Permeability | 1 | 2021 | 42 | 0.180 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2021 | 24 | 0.180 |
Why?
|
| Zinc Oxide | 1 | 2019 | 1 | 0.170 |
Why?
|
| Sunscreening Agents | 1 | 2019 | 5 | 0.170 |
Why?
|
| Mycophenolic Acid | 1 | 2019 | 16 | 0.170 |
Why?
|
| Nanocomposites | 1 | 2019 | 12 | 0.170 |
Why?
|
| Fatty Alcohols | 1 | 2019 | 4 | 0.170 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 124 | 0.170 |
Why?
|
| Anti-Bacterial Agents | 2 | 2021 | 496 | 0.170 |
Why?
|
| Singlet Oxygen | 1 | 2019 | 4 | 0.160 |
Why?
|
| Transplantation, Heterologous | 1 | 2019 | 60 | 0.160 |
Why?
|
| Microscopy, Confocal | 1 | 2019 | 110 | 0.160 |
Why?
|
| Rats | 2 | 2019 | 1545 | 0.160 |
Why?
|
| Lipids | 1 | 2019 | 195 | 0.160 |
Why?
|
| Paclitaxel | 1 | 2019 | 183 | 0.150 |
Why?
|
| Indoles | 1 | 2019 | 98 | 0.150 |
Why?
|
| Polyethylene Glycols | 1 | 2019 | 93 | 0.150 |
Why?
|
| Drug Carriers | 1 | 2019 | 109 | 0.150 |
Why?
|
| Mice | 2 | 2024 | 4406 | 0.140 |
Why?
|
| Acebutolol | 1 | 2015 | 1 | 0.130 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 1 | 2015 | 5 | 0.130 |
Why?
|
| Humans | 5 | 2021 | 26826 | 0.110 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 2019 | 35 | 0.080 |
Why?
|
| Molecular Structure | 2 | 2021 | 239 | 0.070 |
Why?
|
| Quantum Theory | 1 | 2021 | 19 | 0.050 |
Why?
|
| Fluorescence | 1 | 2021 | 48 | 0.050 |
Why?
|
| Bacillus megaterium | 1 | 2021 | 1 | 0.050 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2021 | 101 | 0.050 |
Why?
|
| Particle Size | 1 | 2021 | 96 | 0.040 |
Why?
|
| Surface Properties | 1 | 2021 | 132 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 172 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2021 | 135 | 0.040 |
Why?
|
| Nanoconjugates | 1 | 2020 | 18 | 0.040 |
Why?
|
| Lasers | 1 | 2020 | 67 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2020 | 261 | 0.040 |
Why?
|
| A549 Cells | 1 | 2019 | 16 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2019 | 40 | 0.040 |
Why?
|
| Spheroids, Cellular | 1 | 2019 | 52 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2019 | 166 | 0.040 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2019 | 52 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 264 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2019 | 282 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2021 | 328 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 133 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 1259 | 0.040 |
Why?
|
| Apoptosis | 1 | 2019 | 739 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 2015 | 45 | 0.030 |
Why?
|
| Biocatalysis | 1 | 2015 | 22 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2015 | 149 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 442 | 0.030 |
Why?
|
| Models, Biological | 1 | 2015 | 446 | 0.030 |
Why?
|
| Male | 1 | 2019 | 12869 | 0.010 |
Why?
|
| Female | 1 | 2019 | 14462 | 0.010 |
Why?
|